Impairment Science, Inc.
PrivateLast Round
Grant
Jan 9, 2024
Total Funding Raised
$1.2M
Company Overview
Impairment Science, Inc. operates in Enterprise Software and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in January 2023.
Impairment Science, Inc. is a healthtech company that develops and provides neuroscience-based technology for the detection of cognitive and motor impairment.
Sector
Enterprise Software
Verticals
Compliance & Risk, HR
Business Model
B2B
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Impairment Science, Inc. Comparables
Compare Impairment Science, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Predictive Safety | 88% | |
| SoberEye | 84% | |
| Vocadian | 81% |
For institutional investors. Book with your work email.
Impairment Science, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 9, 2024 | ||||
| Seed | Jan 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Impairment Science, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Aging | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2024
Monthly visitors grew 31% MoM, from 1.3K to 1.7K.
- Apr 28, 2024
Grew 21% QoQ from 14 to 17 employees.
For institutional investors. Book with your work email.
Impairment Science, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Impairment Science, Inc.'s valuation, stock price, and market status.
Is Impairment Science, Inc. a public or private company?
Impairment Science, Inc. is a private company.
What is the current stock price of Impairment Science, Inc.?
Impairment Science, Inc. is a private company, so its shares have no public market price. Caplight tracks Impairment Science, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Impairment Science, Inc. worth (valuation)?
Valuation information for Impairment Science, Inc. is not publicly available.
Can I buy Impairment Science, Inc. stock?
Impairment Science, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Impairment Science, Inc.'s last funding round?
Impairment Science, Inc.'s most recent funding round was Grant on January 9, 2024.
Who are the main investors in Impairment Science, Inc.?
Key investors in Impairment Science, Inc. include National Institute on Aging.
Will Impairment Science, Inc. IPO soon?
No public IPO plans have been announced for Impairment Science, Inc..
How can I track Impairment Science, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Impairment Science, Inc.'s shares on secondary markets.